Welcome to CDC Stacks | Superantigens and Streptococcal Toxic Shock Syndrome - 14235 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Superantigens and Streptococcal Toxic Shock Syndrome
  • Published Date:
    Oct 2003
  • Source:
    Emerg Infect Dis. 9(10):1211-1218.
Filetype[PDF - 352.25 KB]


No Related Documents.
You May Also Like:
  1. Group B Streptococcal Toxic Shock Syndrome and covR/S Mutations Revisited
    Personal Author:
    Sendi, Parham; el Hay, Muad Abd; Brandt, Claudia M.; Spellerberg, Barbara;
    Published:
    Jan 2017
    Source:
    Emerg Infect Dis. 23(1):150-152.
    Description:
    Gene mutations in the virulence regulator CovR/S of group A Streptococcus play a substantial role in the pathogenesis of streptococcal toxic shock syndrome. We screened 25 group B Streptococcus (GBS) isolates obtained from patients with streptococcal...
    File Type:
    Filetype[PDF - 306.53 KB]
  2. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment.
    Personal Author:
    Stevens, D. L.
    Published:
    1995 Jul-Sep
    Source:
    Emerg Infect Dis. 1(3):69-78.
    Description:
    Since the 1980s there has been a marked increase in the recognition and reporting of highly invasive group A streptococcal infections with or without necrotizing fasciitis associated with shock and organ failure. Such dramatic cases have been defined...
    File Type:
    Filetype[PDF - 77.07 KB]
  3. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom
    Personal Author:
    Baxter, Melissa; Morgan, Marina;
    Published:
    Jan 2017
    Source:
    Emerg Infect Dis. 23(1):127-129.
    Description:
    We describe successful management of 3 patients with streptococcal toxic shock syndrome (STSS) attributable to group G Streptococcus infection. This small series supports recognition of group G Streptococcus in the etiology of STSS. We propose intrav...
    File Type:
    Filetype[PDF - 988.73 KB]
  4. Infectious Shock and Toxic Shock Syndrome Diagnoses in Hospitals, Colorado, USA
    Personal Author:
    Smit, Michael A.; Nyquist, Ann-Christine; Todd, James K.;
    Published:
    Nov 2013
    Source:
    Emerg Infect Dis. 19(11):1855-1858.
    Description:
    In Colorado, USA, diagnoses coded as toxic shock syndrome (TSS) constituted 27.3% of infectious shock cases during 1993-2006. The incidence of staphylococcal TSS did not change significantly overall or in female patients 10-49 years of age but increa...
    File Type:
    Filetype[PDF - 582.42 KB]
  5. Staphylococcal Toxic Shock Syndrome 2000–2006: Epidemiology, Clinical Features, and Molecular Characteristics
    Personal Author:
    DeVries, Aaron S.; Lesher, Lindsey; Schlievert, Patrick M.; Rogers, Tyson; Villaume, Lourdes G.; Danila, Richard; Lynfield, Ruth;
    Published:
    Aug 10 2011
    Source:
    PLoS One. 2011; 6(8).
    Description:
    Introduction : Circulating strains of Staphylococcus aureus (SA) have changed in the last 30 years including the emergence of community-associated methicillin-resistant SA (MRSA). A report suggested staphylococcal toxic shock syndrome (TSS) was incre...
    File Type:
    Filetype[PDF - 220.32 KB]